FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to a surface-modified particle containing a particle, which is a ball with a diameter within between or approximately between 2 mcm and 5 mcm, and a binding molecule attached to a surface of the ball, as well as a composition containing it and a kit. A method for reproduction of cells, a method for genetic engineering of cells, a method for selection of a cell, and a method for enrichment of a cell, providing the use of the above-mentioned particle, are also disclosed.
EFFECT: invention is effective for cell stimulation.
53 cl, 25 dwg, 5 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION OF CELL THERAPY AND IMMUNOMODULATOR COMPOUND | 2018 |
|
RU2777911C2 |
| HUMANIZED ANTIBODY TO BCMA AND BCMA-CAR-T CELLS | 2020 |
|
RU2762942C1 |
| HUMANIZED ANTIBODY TO BCMA AND BCMA-CAR-NK-CELLS | 2020 |
|
RU2795443C2 |
| ANTI-BCMA ANTIBODIES CONTAINING ONLY HEAVY CHAIN | 2017 |
|
RU2781301C2 |
| ANTI-IDIOTYPIC ANTIBODIES AND METHODS RELATED TO THEM | 2017 |
|
RU2773355C2 |
| CHIMERIC ANTIGENE RECEPTOR | 2019 |
|
RU2810092C2 |
| CHIMERIC ANTIGENIC RECEPTORS TO BCMA | 2015 |
|
RU2747457C2 |
| TREATMENT OF MALIGNANT NEOPLASM USING HUMANIZED CHIMERIC ANTIGEN RECEPTOR AGAINST BCMA | 2015 |
|
RU2751660C2 |
| METHODS FOR PRODUCING CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR | 2015 |
|
RU2751362C2 |
| NEW CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS CONTAINING TNFR2 DOMAINS | 2019 |
|
RU2808254C2 |
